This quarter, the UK life sciences industry has seen significant improvements in support from both the government and private investors. These new initiatives by the UK government aim to secure the UK’s position as a global leader in life sciences, strengthening its standing in the fields of biotechnology, pharmaceuticals, and medical research.
The latest news across the sector
Eli Lilly recently announced the launch of the first Lilly Gateway Labs in Europe, in collaboration with the UK government. This UK-based initiative aims to support early-stage and start-up biotech companies by providing laboratory space, guidance, and investment to drive innovation in addressing public health challenges, while also supporting NHS efforts to implement effective health solutions nationwide.
